Eli Lilly Raises 2013 Guidance After Q2 Sales Rise

July 24 (Bloomberg) -- Eli Lilly & Co., the maker of the antidepressant Cymbalta and diabetes treatment Humalog, raised its full-year guidance after second-quarter sales grew faster than expected and cost-cutting programs took effect. Olivia Sterns reports on Bloomberg Television's "Market Makers." (Source: Bloomberg)

Have Markets Peaked?: What'd You Miss? (Full Show 04/29)
01:44 - Full episode of "What'd You Miss?" Guests include: Ben Laidler, HSBC Securities global equity strategist, Chris White, Viablemkts chief executive officer, and Meredith Sumpter, Eurasia Group Asia director. (Source: Bloomberg)
  • The Week in Tech From Bloomberg West (04/29)
  • Has Apple's Hot Streak Come to an End?
  • NBC Puts Olympics Video on Snapchat